CIRS Group
Medical Devices
C&K Testing
Carbon Neutrality

Nearly Half of REACH Dossiers Possibly Non-compliant

from Chemical Watch by

According to an analysis performed by German Federal Institute for Risk Assessment (BfR) and the German Environment Agency (UBA), nearly half of the medium tonnage (100-1000tpa) REACH dossiers were non-compliant, especially those with regard to the ecotoxicity. The results confirm the level of compliance with REACH is generally low.

The analysis selected 8 endpoints and combining the analysis for all three checks for the subset of 500 dossiers. Results show that the ecotoxicity section was "non-compliant" in 46% of cases. The non-compliant proportion was lower for the other endpoints, such as reproductive toxicity – with just 9% of cases being ‘non-compliant’.

The equivalent proportion for the high tonnage band was 34%. These proportions give an indication of compliance in general but are not meaningful at the dossier level because a single dossier may be non-compliant in relation to multiple endpoints.

The current analysis is part three of the REACH Compliance project, which the UBA and the BfR launched in 2014 to determine the availability and quality of human health and environmental risk data submitted under REACH.

(Source: Chemical Watch)

CIRS Suggestions

CIRS Experts estimates that more dossiers will undergo compliance checks in the future. Enterprises will possibly need to repeat/redo the tests due to the non-compliance of REACH dossiers. Enterprises may also need to repay the data sharing fee for this reason. It is suggested that enterprises should reassess the European chemical market.


Original News from Chemical Watch in PDF format

Related Info:

ECHA Requires Companies to Provide More Data on Nanoforms

ECHA has Completed Compliance Checks for 50% more REACH Dossiers in 2019


We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Contact Us
+353 1 477 3710 (EU)
+44 20 3239 9430 (UK)
+1 703 520 1420 (USA)
+86 571 8720 6574 (CN)
+82 2 6347 8816 (KR)